Oura Health Oy, the Finnish company behind the Oura Ring, is raising $875 million in a Series E funding round, bringing its valuation to approximately $10.9 billion. This marks a significant increase from its $5 billion valuation during the Series D round in December 2024. The new funds are expected to close by the end of September 2025 and may exceed $900 million. The company plans to use the capital to scale production, invest in product development, and expand internationally.
📊 Company Snapshot
| Metric | Value |
| Valuation (Series E) | $10.9 billion |
| Total Rings Sold | 5.5 million |
| 2024 Revenue | $500 million |
| 2025 Revenue Projection | Over $1 billion |
| 2026 Sales Forecast | Over $1.5 billion |
| Global Retail Presence | 4,000 stores in 20 countries |
🚀 Growth Drivers
- Strong Sales Momentum: Oura sold approximately 3 million rings over the past year, contributing to its rapid growth.
- Strategic Partnerships: Collaborations with companies like Dexcom for glucose monitoring and the U.S. military for health tracking have expanded Oura’s market reach.
- Product Innovation: The launch of the Oura Ring 4 and the integration of continuous glucose monitoring data have enhanced the ring’s utility in health tracking.
Oura’s focus on health insights through wearable technology positions it as a leader in the growing wearable health tech market, which is projected to reach $168 billion by 2030. The company’s discreet ring design and AI-driven personalization cater to consumers seeking continuous, passive health data collection. With strong institutional backing and a broad retail presence, Oura is well-positioned for continued growth and innovation.
